Envoy Medical COCH Stock Issued During Period Value Purchase Exercise Of Forward Purchase Agreement Warrant
Stock Issued During Period Value Purchase Exercise Of Forward Purchase Agreement Warrant at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept coch:StockIssuedDuringPeriodValuePurchaseExerciseOfForwardPurchaseAgreementWarrant.
The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's stock issued during period value purchase exercise of forward purchase agreement warrant.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's stock issued during period value purchase exercise of forward purchase agreement warrant?
- Envoy Medical (COCH) reported stock issued during period value purchase exercise of forward purchase agreement warrant of $777.75K in Q4 2025.
- How has Envoy Medical's stock issued during period value purchase exercise of forward purchase agreement warrant changed year-over-year?
- Envoy Medical's stock issued during period value purchase exercise of forward purchase agreement warrant increased by 71.4% year-over-year, from $453.75K to $777.75K.
- What does stock issued during period value purchase exercise of forward purchase agreement warrant mean?
- The total value of common stock issued during the period due to the exercise of warrants associated with forward purchase agreements. This metric tracks the conversion of derivative instruments into equity and the resulting capital inflow.